BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38099195)

  • 1. Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles.
    Brokāne A; Bajo-Santos C; Zayakin P; Belovs A; Jansons J; Lietuvietis V; Martens-Uzunova ES; Jenster GW; Linē A
    Front Mol Biosci; 2023; 10():1279854. PubMed ID: 38099195
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma and urinary extracellular vesicles as a source of RNA biomarkers for prostate cancer in liquid biopsies.
    Bajo-Santos C; Brokāne A; Zayakin P; Endzeliņš E; Soboļevska K; Belovs A; Jansons J; Sperga M; Llorente A; Radoviča-Spalviņa I; Lietuvietis V; Linē A
    Front Mol Biosci; 2023; 10():980433. PubMed ID: 36818049
    [No Abstract]   [Full Text] [Related]  

  • 3. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
    Dong L; Hu C; Ma Z; Huang Y; Shelley G; Kuczler MD; Kim CJ; Witwer KW; Keller ET; Amend SR; Xue W; Pienta KJ
    Res Sq; 2024 Mar; ():. PubMed ID: 38585988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer.
    Matsuzaki K; Fujita K; Tomiyama E; Hatano K; Hayashi Y; Wang C; Ishizuya Y; Yamamoto Y; Hayashi T; Kato T; Jingushi K; Kawashima A; Ujike T; Nagahara A; Uemura M; Tsujikawa K; Nonomura N
    Transl Androl Urol; 2021 Apr; 10(4):1918-1927. PubMed ID: 33968679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling in tissues and urine of patients with prostatic lesions and the diagnostic value of urine extracellular vesicles metabolites in prostate cancer.
    Ding T; He W; Yan H; Wei Z; Zeng X; Hao X
    Clin Chim Acta; 2024 Mar; 556():117845. PubMed ID: 38403146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia.
    Abramovic I; Vrhovec B; Skara L; Vrtaric A; Nikolac Gabaj N; Kulis T; Stimac G; Ljiljak D; Ruzic B; Kastelan Z; Kruslin B; Bulic-Jakus F; Ulamec M; Katusic-Bojanac A; Sincic N
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles-A Source of RNA Biomarkers for the Detection of Breast Cancer in Liquid Biopsies.
    Zayakin P; Sadovska L; Eglītis K; Romanchikova N; Radoviča-Spalviņa I; Endzeliņš E; Liepniece-Karele I; Eglītis J; Linē A
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers.
    Worst TS; Previti C; Nitschke K; Diessl N; Gross JC; Hoffmann L; Frey L; Thomas V; Kahlert C; Bieback K; Crigna AT; Fricke F; Porubsky S; Westhoff N; Hardenberg JV; Nuhn P; Erben P; Michel MS; Boutros M
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
    Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
    Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
    Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression.
    Clos-Garcia M; Loizaga-Iriarte A; Zuñiga-Garcia P; Sánchez-Mosquera P; Rosa Cortazar A; González E; Torrano V; Alonso C; Pérez-Cormenzana M; Ugalde-Olano A; Lacasa-Viscasillas I; Castro A; Royo F; Unda M; Carracedo A; Falcón-Pérez JM
    J Extracell Vesicles; 2018; 7(1):1470442. PubMed ID: 29760869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of piRNA Targets in Urinary Extracellular Vesicles for the Diagnosis of Prostate Cancer.
    Peng Q; Chiu PK; Wong CY; Cheng CK; Teoh JY; Ng CF
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of micro-RNA in extracellular vesicles from blood of patients with prostate cancer.
    Kim J; Cho S; Park Y; Lee J; Park J
    PLoS One; 2021; 16(12):e0262017. PubMed ID: 34972164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis.
    Hamed MA; Wasinger V; Wang Q; Graham P; Malouf D; Bucci J; Li Y
    J Control Release; 2024 May; 371():126-145. PubMed ID: 38768661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis.
    Pang B; Zhu Y; Ni J; Ruan J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Int J Nanomedicine; 2020; 15():10241-10256. PubMed ID: 33364756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of miRNAs in Plasma Extracellular Vesicle for the Stratification of Prostate Cancer in a South African Population.
    Temilola DO; Wium M; Paccez J; Salukazana AS; Otu HH; Carbone GM; Kaestner L; Cacciatore S; Zerbini LF
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.